BioPharma Credit (LON:BPCR - Get Free Report) reached a new 52-week high during mid-day trading on Monday . The stock traded as high as GBX 0.91 ($0.01) and last traded at GBX 0.90 ($0.01), with a volume of 642677 shares. The stock had previously closed at GBX 0.90 ($0.01).
BioPharma Credit Stock Performance
The company's 50 day moving average price is GBX 0.87 and its 200-day moving average price is GBX 0.87. The stock has a market cap of £1.06 billion, a P/E ratio of 10.19 and a beta of 0.22.
BioPharma Credit Cuts Dividend
The company also recently disclosed a dividend, which was paid on Wednesday, May 7th. Shareholders of record on Thursday, April 3rd were given a $0.02 dividend. This represents a yield of 1.99%. The ex-dividend date was Thursday, April 3rd. BioPharma Credit's payout ratio is 7,957.15%.
About BioPharma Credit
(
Get Free Report)
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider BioPharma Credit, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BioPharma Credit wasn't on the list.
While BioPharma Credit currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
